Background. Peripheral axon regeneration is improved when the nerve lesion under
consideration has recently been preceded by another nerve injury. This is known as the …

The injection of safe doses of botulinum neurotoxin A (BoNT/A) have been reported to be
useful for the treatment of neuropathic pain, but it is still unknown how functional recovery is …

Botulinum neurotoxin A (BoNT) and brain‐derived neurotrophic factor (BDNF) are known for
their ability to influence synaptic inputs to neurons. Here, we tested if these drugs can …

Botulinum toxin is becoming increasingly popular as the drug of choice for relief of spasticity
in a wide range of conditions, from stroke to strabismus to vaginismus. Besides this role as …

Botulinum toxin A (BoNT‐A) is a bacterial zinc‐dependent endopeptidase that acts
specifically on neuromuscular junctions. BoNT‐A blocks the release of acetylcholine …

This study was designed to compare the effects of various doses of botulinum neurotoxin A
(BoNT/A) on nerve regeneration. Sixty-five six-week-old rats with sciatic nerve injury were …

Botulinum neurotoxins (BoNTs) are extremely potent neuromuscular poisons that act
through soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) …

Axons regenerate more rapidly after a test lesion if they received a conditioning lesion.
Previous work suggests that the cell body reaction to injury is responsible for this …

Traumatic peripheral nerve injuries tend to be more common in younger, working age
populations and can lead to long-lasting disability. Peripheral nerves have an impressive …

Xeomin® is a commercial formulation of botulinum neurotoxin type A (BoNT/A) clinically
authorized for treating neurological disorders, such as blepharospasm, cervical dystonia …